Changing epidemiology of candidemia in a medical center in middle Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 3, 2015, Pages 306-315

  Hii, Ing Moi ^a   Chang, Hui Lan ^a   Lin, Li Chen ^a   Lee, Yu Lin ^a   Liu, Yuag Meng ^a   Liu, Chun Eng ^a   Chen, Chang Hua ^a   Cheng, Yu Ren ^a   Chang, Chih Yen ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Antifungal susceptibility; Candida species; Candidemia

Indexed keywords

ECHINOCANDIN; FLUCONAZOLE; ANTIFUNGAL AGENT;

ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; APACHE; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; FEMALE; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEYEROZYMA GUILLIERMONDII; MORTALITY; NEUTROPENIA; PARENTERAL NUTRITION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; TAIWAN; TREATMENT OUTCOME; CANDIDA; CLASSIFICATION; CROSS INFECTION; DEMOGRAPHY; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; SURVIVAL ANALYSIS; TERTIARY CARE CENTER; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CROSS INFECTION; DEMOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SURVIVAL ANALYSIS; TAIWAN; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84929507067     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.08.017     Document Type: Article

References (33)

1. Hidron A.I., Edwards J.R., Patel J., Horan T., Sievert D.M., Pollock D.A., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hospl Epidemiol 2008, 29:996-1011.
2. Liu C.Y., Liao C.H., Chen Y.C., Chang S.C. Changing epidemiology of nosocomial bloodstream infections in 11 teaching hospitals in Taiwan between 1993 and 2006. J Microbiol, Immunol Infect 2010, 43:416-429.
3. Hobson R.P. The global epidemiology of invasive Candida infections-is the tide turning?. J Hosp Infect 2003, 55:159-168.
4. Ruan S.Y., Hsueh P.R. Invasive candidiasis overview: An overview from Taiwan. J Formos Med Assoc 2009, 108:443-451.
5. Horn D.L., Neofytos D., Anaissie E.J., Fishman J.A., Steinbach W.J., Olyaei A.J., et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009, 48:1695-1703.
6. Pfaller M.A., Pappas P.G., Wingard J.R. Invasive fungal pathogens: Current epidemiological trends. Clin Infect Dis 2006, 43:S3-S14.
7. Cheng M.F., Yang Y.L., Yao T.J., Lin C.Y., Liu J.S., Tang R.B., et al. Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis 2005, 5:22.
8. Richardson M.D. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005, 56:i5-i11.
9. Chang F.Y. Statistics communicable diseases and surveillance report 2011 October 2012, Centers for Disease Control, Department of Health, R. O. C. (Taiwan).
10. Cheng Y.R., Lin L.C., Young T.G., Liu C.E., Chen C.H., Tsay R.W. Risk factors for candidemia-related mortality at a medical center in central Taiwan. J Microbiol Immunol Infect 2006, 39:155-161.
11. Garner J.S., Jarvis W.R. CDC definition of nosocomial infection 1998.
12. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
13. Wayne P. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard 2008, Clinical and Laboratory Standards Institute, CLSI document M27-A3, Clinical and Laboratory Standards Institute. 3rd ed.
14. Chen P.Y., Chuang Y.C., Wang J.T., Sheng W.H., Yu C.J., Chu C.C., et al. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010. J Microbiol Immunol Infect 2014, 47:95-103.
15. Lo H.J., Cheng H.H. Distribution of clinical yeasts in Taiwan. Fung Sci 2005, 20:83-91. TSARY hospitals.
16. Tsai C.C., Wang C.C., Kuo H.Y., Chiang D.H., Lin M.L., Liu C.Y., et al. Adult candidemia at a medical center in northern Taiwan: a retrospective study. J Microbiol Immunol Infect 2008, 41:414-421.
17. Chen L.Y., Liao S.Y., Kuo S.C., Chen S.J., Chen Y.Y., Wang F.D., et al. Changes in the incidence of candidaemia during 2000-2008 in a tertiary medical centre in northern Taiwan. J Hosp Infect 2011, 78:50-53.
18. Yang Y.L., Cheng H.H., Lo H.J. Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan. Med Mycol 2006, 44:237-242.
19. Hsueh P.R., Lau Y.J., Chuang Y.C., Wan J.H., Huang W.K., Shyr J.M., et al. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother 2005, 49:512-517.
20. Chen P.L., Lo H.J., Wu C.J., Lee H.C., Chang C.M., Lee N.Y., et al. Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006. Mycoses 2011, 54:e17-e23.
21. Tapia G.G., Razonable R.R., Eckel Passow J.E., Lahr B.D., Afessa B., Keegan M.T., et al. A scoring model of factors associated with Candida glabrata candidemia among critically ill patients. Mycoses 2012, 55:228-236.
22. Ruan S.Y., Huang Y.T., Chu C.C., Yu C.J., Hsueh P.R. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes. Int J Antimicrob Agents 2009, 34:236-239.
23. Ben-Ami R., Olshtain-Pops K., Krieger M., Oren I., Bishara J., Dan M., et al. Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother 2012, 56:2518-2523.
24. Cohen Y., Karoubi P., Adrie C., Gauzit R., Marsepoil T., Zarka D., et al. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. Crit Care Med 2010, 38:826-830.
25. Lee I., Morales K.H., Zaoutis T.E., Fishman N.O., Nachamkin I., Lautenbach E. Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections. Am J Infect Control 2010, 38:740-745.
26. Malani A., Hmoud J., Chiu L., Carver P.L., Bielaczyc A., Kauffman C.A. Candida glabrata fungemia: experience in a tertiary hospital. Clin Infect Dis 2005, 41:975-981.
27. Leon E.M., Jacober S.J., Scobel J.D., Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis 2002, 2:1.
28. Ruan S.Y., Chu C.C., Hsueh P.R. In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. Antimicrob Agents Chemother 2008, 52:2919-2922.
29. Lombardi G., Farina C., Andreoni S., Fazii P., Faggi E., Pini G., et al. Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts. Mycoses 2004, 47:397-401.
30. Tumbarello M., Sanguinetti M., Trecarichi E.M., Sorda M.L., Rossi M., Carolis E.D., et al. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome. J Antimicrob Chemother 2008, 62:1379-1385.
31. Andes D.R., Safdar N., Baddley J.W., Playford G., Reboli A.C., Rex J.H., et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 2012, 54:1110-1122.
32. Blot S., Vandewoude K., Hoste E., Poelaert J., Colardyn F. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata. J Hosp Infect 2001, 47:308-313.
33. Chen T.C., Chen Y.H., Tsai J.J., Peng C.F., Lu P.L., Chang K., et al. Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan. J Microbiol Immunol Infect 2005, 38:200-210.